Article Versions Notes

Sasaki N, Gomi F, Yoshimura H, Yamamoto M, Matsuda Y, Michishita M, Hatakeyama H, Kawano Y, Toyoda M, Korc M, et al. FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer. Cancers. 2020; 12(10):2976. https://doi.org/10.3390/cancers12102976

Sasaki, Norihiko, Fujiya Gomi, Hisashi Yoshimura, Masami Yamamoto, Yoko Matsuda, Masaki Michishita, Hitoshi Hatakeyama, Yoichi Kawano, Masashi Toyoda, Murray Korc, and et al. 2020. "FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer" Cancers 12, no. 10: 2976. https://doi.org/10.3390/cancers12102976

Sasaki, N., Gomi, F., Yoshimura, H., Yamamoto, M., Matsuda, Y., Michishita, M., Hatakeyama, H., Kawano, Y., Toyoda, M., Korc, M., & Ishiwata, T. (2020). FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer. Cancers, 12(10), 2976. https://doi.org/10.3390/cancers12102976